I-Mab Biopharma signs licensing agreement for HyLeukin with Genexine

I-Mab receives exclusive development and commercialization rights to HyLeukin in China, China Taiwan, Hong Kong and Macao Genexine, a clinical stage biotechnology company developing innovative biologics, today announced the signing of a licensing agreement with I-Mab to develop and commercialize a ...


Official Website Online!

With all our efforts, Third Venture Biopharma's official website (in Chinese) was officially in public test phase on 21 March 2017. We hope that we can serve for our clients in a more prudent and professional manner. TVB will consistently move forward responsible for our staff and various clients.